Vanguard Group Inc Eargo, Inc. Transaction History

Vanguard Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.49 - $0.73 $175,346 - $261,231	357,851 Added 88.03%	764,349 $435,000
Q3 2022 Nov 14, 2022	SELL	$0.7 - $3.0 $278,225 - $1.19 Million	-397,465 Reduced 49.44%	406,498 $427,000
Q2 2022 Aug 12, 2022	SELL	$0.75 - $5.6 $114,894 - $857,880	-153,193 Reduced 16.01%	803,963 $605,000
Q1 2022 May 13, 2022	SELL	$3.3 - $7.28 $2.04 Million - $4.5 Million	-617,678 Reduced 39.22%	957,156 $5.06 Million
Q4 2021 Feb 14, 2022	SELL	$4.6 - $10.21 $1.46 Million - $3.25 Million	-318,095 Reduced 16.8%	1,574,834 $8.03 Million
Q3 2021 Nov 12, 2021	BUY	$6.59 - $38.71 $1.6 Million - $9.42 Million	243,401 Added 14.76%	1,892,929 $12.7 Million
Q2 2021 Aug 13, 2021	BUY	$32.1 - $57.78 $52.9 Million - $95.3 Million	1,649,528 New	1,649,528 $65.8 Million

33.4K

Ticker EAR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 39,411,000
Market Cap $2.78B
Description
Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. The company markets and sells hearing aids. It sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.